IMMUNOGENICITY OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN PATIENTS WITH VASCULITIS RECEIVING STANDARD OF CARE THERAPY AND CONTROLS

被引:0
|
作者
Nived, P. [1 ]
Nagel, J. [1 ]
Saxne, T. [1 ]
Geborek, P. [1 ]
Jonsson, G. [1 ]
Skattum, L. [1 ]
Kapetanovic, M. C. [1 ]
机构
[1] Lund Univ, Lund, Sweden
关键词
D O I
10.1136/annrheumdis-2016-eular.2764
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
FRI0386
引用
收藏
页码:574 / 574
页数:1
相关论文
共 50 条
  • [31] Immunogenicity and safety of single-dose, 13-valent pneumococcal conjugate vaccine in pediatric and adolescent oncology patients
    Hung, Te-Yu
    Kotecha, Rishi S.
    Blyth, Christopher C.
    Steed, Sarah K.
    Thornton, Ruth B.
    Ryan, Anne L.
    Cole, Catherine H.
    Richmond, Peter C.
    CANCER, 2017, 123 (21) : 4215 - 4223
  • [32] Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed) [Prevenar 13®]
    Sean T. Duggan
    Drugs, 2010, 70 : 1973 - 1986
  • [33] Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine administered to older infants and children naive to pneumococcal vaccination
    Wysocki, Jacek
    Brzostek, Jerzy
    Szymanski, Henryk
    Tetiurka, Boguslaw
    Toporowska-Kowalska, Ewa
    Wasowska-Krolikowska, Krystyna
    Sarkozy, Denise A.
    Giardina, Peter C.
    Gruber, William C.
    Emini, Emilio A.
    Scott, Daniel A.
    VACCINE, 2015, 33 (14) : 1719 - 1725
  • [34] Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine
    Miller, Elizabeth
    Andrews, Nicholas J.
    Waight, Pauline A.
    Slack, Mary P. E.
    George, Robert C.
    VACCINE, 2011, 29 (49) : 9127 - 9131
  • [35] Efficacy of 13-valent pneumococcal conjugate vaccine in healthcare workers
    Shpagina, L. A.
    Kotova, O. S.
    Shpagin, I. S.
    Loktin, E. M.
    Rukavitsyna, A. A.
    Kuznetsova, G., V
    Kamneva, N., V
    Laletina, M. A.
    TERAPEVTICHESKII ARKHIV, 2018, 90 (11) : 55 - 61
  • [36] Pneumococcal 13-valent conjugate vaccine administration after inferior response to pneumococcal vaccine
    Gupta, Ratika
    Wong, Chak Shui
    Fonacier, Luz
    ALLERGY AND ASTHMA PROCEEDINGS, 2017, 38 (05) : 365 - 369
  • [37] Safety and immunogenicity of a multivalent pneumococcal conjugate vaccine given with 13-valent pneumococcal conjugate vaccine in healthy infants: A phase 2 randomized trial
    Simon, Michael W.
    Bataille, Regine
    Caldwell, Nicole S.
    Gessner, Bradford D.
    Jodar, Luis
    Lamberth, Erik
    Peng, Yahong
    Scott, Daniel A.
    Lei, Lanyu
    Giardina, Peter C.
    Gruber, William C.
    Jansen, Kathrin U.
    Thompson, Allison
    Watson, Wendy
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (02)
  • [38] Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults Previously Vaccinated With Pneumococcal Polysaccharide Vaccine
    Glesby, Marshall J.
    Watson, Wendy
    Brinson, Cynthia
    Greenberg, Richard N.
    Lalezari, Jacob P.
    Skiest, Daniel
    Sundaraiyer, Vani
    Natuk, Robert
    Gurtman, Alejandra
    Scott, Daniel A.
    Emini, Emilio A.
    Gruber, William C.
    Schmoele-Thoma, Beate
    JOURNAL OF INFECTIOUS DISEASES, 2015, 212 (01): : 18 - 27
  • [39] Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Followed by the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) in Adults with and without Immunosuppressive Therapy
    Garcia Garrido, Hannah M.
    Vollaard, Albert
    D'Haens, Geert R.
    Spuls, Phyllis I.
    Bemelman, Frederike J.
    Tanck, Michael W.
    de Bree, Godelieve J.
    Meek, Bob
    Grobusch, Martin P.
    Goorhuis, Abraham
    VACCINES, 2022, 10 (05)
  • [40] Bacteremic Pneumococcal Pneumonia And Potential Role Of Pneumococcal 13-Valent Conjugate Vaccine
    Novella Sanchez, L.
    Sanz Herrero, F.
    Fernandez-Fabrellas, E.
    Gimeno Cardona, C.
    Tormo, N.
    Chiner, E.
    Cervera, A.
    Briones, M.
    Aguar, M.
    Lera, R.
    Blanquer, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189